BCRWA @ The 64th ASH Annual Meeting & Exposition 2022

Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Dr. Kat Lewis Receives Cancer Council WA Early Career Researcher of the Year 2022

HIRING: Clinical Research Fellow

WATCH: Professor Chan Cheah @ Blood, Sweat and Tears of Joy

Professor Cheah featured on @9newsperth

BCRWA Scientific Sundowner

Umbralisib Results from UNITY-NHL study published in the Journal of Clinical Oncology

Snowdome Annual Review for 2020